Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02016885 · ClinicalTrials.gov registry record · Phase 2
A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
A Phase 2 study, sponsored by Journey Medical Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 198
- Enrollment target
NCT02016885: Completed Phase 2 study, sponsored by Journey Medical Corporation.
NCT02016885 is a Phase 2 study that has completed, run by Journey Medical Corporation. The registered enrollment target is 198 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (49% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02016885, a Phase 2 study, has completed, sponsored by Journey Medical Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 198 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of glycopyrrolate compared to vehicle for the treatment of axillary hyperhidrosis.
Primary Outcome
HDSS is a disease specific diagnostic tool that provides a qualitative measure of the severity of the subjects' condition based on how it affects daily activities. 1 (Best), 2, 3, 4 (Worst)
Interventions
- OTHER Vehicle
- DRUG glycopyrrolate, 1.0%
- DRUG glycopyrrolate, 2.0%
- DRUG glycopyrrolate, 3.0%
- DRUG glycopyrrolate, 4.0%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-09 |
| Phase | Phase 2 |
What the finished NCT02016885 record still lists
NCT02016885 is an interventional study that assigns participants to a tested intervention. The registered 198 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (49% higher).
The record links to 0 conditions, and to 5 interventions - of which Vehicle is the first listed.
NCT02016885 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02016885 about?
NCT02016885 is a clinical study titled "A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis". The purpose of this study is to evaluate the safety and efficacy of glycopyrrolate compared to vehicle for the treatment of axillary hyperhidrosis.
What is the current status of trial NCT02016885?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 198 participants. The study started on 2013-11. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02016885?
The interventions under investigation include: Vehicle (OTHER), glycopyrrolate, 1.0% (DRUG), glycopyrrolate, 2.0% (DRUG), glycopyrrolate, 3.0% (DRUG), glycopyrrolate, 4.0% (DRUG).
Who is sponsoring clinical trial NCT02016885?
This trial is sponsored by Journey Medical Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02016885's enrollment target sits among peer trials
198 349th of 2000 higher than 1,652 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
- NCT05561114 · 198 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
- NCT05585190 · 198 participants · NA
Stand Up for Your Health with a Sit-stand Desk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia